N@N

Market Maker Surveillance Report. ALDA, BDCO, DYSL, MNOV, CHME, SBAY, Losing Stocks With Lowest Price Friction For Thursday, M

March 24, 2011 / M2 PRESSWIRE / BUYINS.NET / www.buyins.net, announced today its proprietary Market Maker Friction Factor Report for Thursday. Since October 2008 market makers are now required to be on the bid as much as they are on the offer and for like amounts of stock. This Fair Market Making Requirement is designed to prevent market makers from manipulating stock prices. On Thursday there were 2484 companies with "abnormal" market making, 3282 companies with positive Friction Factors and 1911 companies with negative Friction Factors. Here is a list of the top companies with the largest percentage loss per share Thursday and low price friction (bearish). This means that there was more selling than buying in the stocks and their stock prices dropped faster with less Friction. ALDILA INC (OTC:ALDA), BLUE DOLPHIN ENERGY CO (NASDAQ:BDCO), DYNASIL CORP OF AMERICA (OTCBB:DYSL), MEDICINOVA INC (NASDAQ:MNOV), CHINA MEDICINE CORP (OTCBB:CHME), SUBAYE INC (NASDAQ:SBAY). To access Friction Factor, Naked Short Data and SqueezeTrigger Prices on all stocks please visit http://www.buyins.net .

Market Maker Friction Factor is shown in the chart below:

     Symbol     Change       Percent      Buy Volume      Buy %%       Sell Volume     Sell %%      Net Volume      Friction
     ALDA       $-1.000      -18.18%      29,600          37.37%       49,600          62.63%       -20,000         -200    
     BDCO       $-0.820      -11.13%      96,275          43.38%       121,734         54.86%       -25,459         -310    
     DYSL       $-0.930      -16.01%      206,168         47.36%       223,580         51.36%       -17,412         -187    
     MNOV       $-0.960      -26.97%      709,403         42.30%       965,036         57.55%       -255,633        -2,663  
     CHME       $-0.620      -53.45%      69,422          27.34%       184,459         72.66%       -115,037        -1,855  
     SBAY       $-0.710      -18.98%      150,634         40.12%       222,495         59.26%       -71,861         -1,012  

Analysis of the Friction Factor chart above shows that each of the six stocks mentioned above have high net dollar losses (Change) and extremely low price friction in their stocks. The Friction Factor displays how many more shares of buying than selling are required to move a stock higher by one cent or how many more shares of selling than buying moves a stock lower by 1 cent.

For example, the chart above shows ALDA with a dollar loss Thursday of $-1.00000 and a Friction Factor of -200 shares. That means that it only took 200 more shares of selling than buying to move ALDA lower by one penny. This means the Market Makers are allowing the stock to drop quickly (low friction). The combination of low friction and negative market direction can drive prices lower faster than normal.

ALDILA INC (OTC:ALDA) - Aldila, Inc., through its subsidiaries, engages in the design, manufacture, and marketing of graphite golf club shafts primarily in the United States. The companys golf shafts are composite structures consisting principally of carbon fiber and epoxy resins, as well as boron or fiberglass. In addition, it offers composite prepregs and other related composite materials. The company sells its graphite shafts to golf club manufacturers, distributors, custom club shops, pro shops, and repair shops; and composite materials to manufacturers of composite products. It primarily operates in Europe, the United States, England, the Peoples Republic of China, Canada, Australia, and Vietnam. The company was founded in 1972 and is based in Poway, California.

BLUE DOLPHIN ENERGY CO (NASDAQ:BDCO) - Blue Dolphin Energy Company, through its subsidiaries, engages in the provision of pipeline transportation and related services for producers/shippers, and exploration and production of oil and gas in the United States. Its pipeline transportation and related services include the operation of the Blue Dolphin Pipeline system, which comprise the offshore segment that transports gas and condensate, and consists of approximately 34 miles of 20-inch pipeline from a offshore platform in Galveston Area Block 288 to shore, as well as the platform in Galveston Area Block 288 and 5 field gathering lines totaling approximately 27 miles connected to the main 20-inch line; and the onshore segment consisting of approximately 2 miles of 16-inch pipeline for the transportation of gas from onshore facility to a sales point at a chemical plant complex and intrastate pipeline system tie-in in Freeport, Texas. The companys pipeline systems also include the Buccaneer Pipeline, an 8-inch liquids pipeline, which transports condensate from the onshore facility storage tanks to the company's barge-loading terminal on the Intracoastal Waterway near Freeport, Texas for sale to third parties; and the Galveston Area Block 350 Pipeline consisting of 8-inch, 13 mile offshore pipeline extending from Galveston Area Block 350 to an interconnect with a transmission pipeline in Galveston Area Block 391. In addition, it holds interests in oil and gas properties located in the western Gulf of Mexico off the Texas coast. The company was founded in 1986 and is based in Houston, Texas.

DYNASIL CORP OF AMERICA (OTCBB:DYSL) - Dynasil Corporation of America, through its subsidiaries, engages in the development, manufacture, and marketing of optical products and optical instruments, as well as contract research in the United States and internationally. Its products include optical instruments, as well as components that are used for optical instruments, lasers, analytical instruments, semiconductor/electronic devices, automotive components, spacecraft/aircraft components, and in devices for the solar energy industry. The company also produces various analytical instruments, including instruments designed to measure the Sun Protection Factor of sunscreens, handheld instruments to determine whether there is lead in the paint of buildings and whether electronics are in compliance with the reduction of hazardous substances regulations, and medical probes that reduce the scope of cancer surgery. Dynasil Corporation distributes its products through its direct sales force domestically, as well as through manufacturers representatives internationally. The company was founded in 1960 and is based in West Berlin, New Jersey.

MEDICINOVA INC (NASDAQ:MNOV) - MediciNova, Inc., a biopharmaceutical company, engages in the acquisition and development of small molecule therapeutics for the treatment of diseases with unmet medical needs principally in the United States. The companys development pipeline includes programs that are in clinical development for the treatment of asthma, acute exacerbations of asthma, multiple sclerosis, central nervous system disorders, interstitial cystitis, solid tumor cancers, generalized anxiety disorder/insomnia, preterm labor, and urinary incontinence. Its principal product development programs consist of MN-221, which completed Phase II clinical trial for the treatment of acute exacerbations of asthma, and completed Phase Ib clinical trial for the treatment of chronic obstructive pulmonary disease; MN-166 that has completed Phase II clinical trial for the treatment of multiple sclerosis; and AV411, which has advanced through multiple Phase I and IIa clinical trials for the treatment of central nervous system disorders. The companys other product development programs include MN-001, which completed Phase II/III clinical trial for the treatment of interstitial cystitis and an oral dosing formulation prototype for the treatment of bronchial asthma; MN-029 that completed Phase I clinical trial for the treatment of solid tumors; MN-305, which completed Phase II/III clinical trial for the treatment of generalized anxiety disorder and Phase II clinical trial for the treatment of insomnia; MN-221 that completed a Phase I clinical trial for the treatment of preterm labor; and MN-246, a Phase I clinical trial completed product for the treatment of urinary incontinence. Its preclinical development products comprise MN-447 and MN-462 for the treatment of thrombotic disorders. The company was founded in 2000 and is headquartered in San Diego, California.

CHINA MEDICINE CORP (OTCBB:CHME) - China Medicine Corporation, through its subsidiaries, distributes pharmaceutical and medical products in the Peoples Republic of China. It sells and distributes approximately 2,100 pharmaceutical and medical products that include prescription and over-the-counter drugs, Chinese herbs, traditional Chinese medicines, nutritional supplements, dietary supplements, and medical instruments, as well as intellectual property. The company is also developing and manufacturing vascular medicines, anti-inflammatory medicines, medicines for womens health, and other general health traditional Chinese medicines. China Medicine Corporation serves primarily pharmaceutical product wholesalers, hospitals, and retail drug stores. The company is based in Guangzhou, the Peoples Republic of China.

SUBAYE INC (NASDAQ:SBAY) - Subaye, Inc. provides video advertising and entertainment media services to small and medium sized enterprises in China. It operates in three segments: Online Membership Services, Entertainment Media, and Trade Services. The Online Membership Services segment provides online content and member services for commercial use. The Entertainment Media segment produces and places advertising solutions on behalf of its customers and invests in entertainment arts productions. The Trade Services segment provides domestic and international importing and exporting services to acquire and distribute goods within China or internationally. Subaye, Inc. offers SaaS online content management software to manage members online video and graphic showcases and operations within their Webshops at the online shopping mall and to maintain customer data. As of November 30, 2009, the company had 63,311 members. Its video database consisted of 72,126 profiles of corporate video showcases that offer venue for small to mid-size enterprises to advertise their products and services, and establish and enhance their corporate brands. The company was formerly known as MyStarU.com, Inc. and changed its name to Subaye, Inc. in October 2009. Subaye, Inc. was founded in 1997 and is headquartered in Guangzhou, the Peoples Republic of China.

About BUYINS.NET

BUYINS.NET, www.buyins.net , monitors trading in all US stocks in real time and maintains massive databases of short sale and naked short sale time and sales data, short squeeze SqueezeTrigger prices, market maker price movements, shareholder data, statistical data on earnings, sector correlation, seasonality, hedge fund trading strategies, comparable valuations. Reports include:

REGULATORY & COMPLIANCE NEWS

Friction Factor -- market maker surveillance system tracking Level II market makers in all stocks to determine Price Friction and compliance with new "Fair Market Making Requirements"

RegSHO Naked Shorts -- tracks EVERY failure to deliver in all US stocks and tracks all Threshold Security Lists daily for which stocks have naked shorts that are not in compliance with Regulation SHO

INVESTMENTS & TRADING

SqueezeTrigger -- 29 billion cell database tracks EVERY short sale (not just total short interest) in all US stocks and calculates volume weighted price that a short squeeze will begin in each stock.

Earnings Edge -- predicts probability, price move and length of move before and after all US stock earnings reports.

Seasonality -- predicts probability, price move and length of move based on exact time of year for all US stocks.

Group Trader -- tracks sector rotation and stock correlation to its sector and predicts future moves in ALL sectors and industry groups.

Pattern Scan -- automates tracking of every technical pattern and predicts time and size of move in all stocks.

GATS (Global Automated Trading System) -- tracks all known trading strategies and qualifies and quantifies which are working best in real time.

DISCLAIMER:

BUYINS.NET is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell any securities. BUYINS.NET has not been compensated by any of the above mentioned companies. Past performance is not indicative of future results. Please visit our web site, www.buyins.net , for complete risks and disclosures.

Contact:

BUYINS.NET Thomas Ronk 800-715-9999 tom@buyins.net www.buyins.net